• Okadaic acid: PP1/PP2A Workflow Guide

  2026-09-17

  Okadaic acid provides a practical way to distinguish PP2A-dominant from higher-concentration PP1/PP2A phosphatase inhibition in biochemical and cell-based studies. This guide covers concentration planning, solvent controls, apoptosis readouts, and limitations; it is not intended for broad-spectrum phosphatase inhibition or workflows that cannot tolerate the supplied ethanol vehicle.

• SFRP1, Wnt/β-Catenin, and Oral Fibrosis

  2026-09-16

  A 2024 study shows that reduced SFRP1 is associated with neutrophil infiltration, fibrosis, and increased Wnt/β-catenin activity in an arecoline-induced oral submucous fibrosis model. SFRP1 overexpression reduced these pathological features, while pathway activation reversed the protective effect, providing a mechanistic framework for studying inflammatory and fibrotic signaling in OSF.

• Streptavidin-FITC for Biotin Tracking Workflows

  2026-09-15

  Streptavidin-FITC converts biotinylated antibodies, proteins, and nucleic acids into measurable green fluorescence across imaging and flow-based assays. This guide connects practical staining design with a recent lipid nanoparticle trafficking study, emphasizing controls that distinguish true intracellular localization from labeling artifacts.

• Long-Term Outcomes of mRNA DC Therapy in Melanoma

  2026-09-15

  The reference study evaluated autologous dendritic cells electroporated with multiple melanoma-antigen mRNAs in patients who were free of detectable disease after complete metastasis resection. Its long follow-up supports the feasibility and tolerability of this adjuvant strategy, while the single-center, non-randomized design means that the encouraging survival outcomes require controlled validation.

• LDH Cytotoxicity Assay Kit: Practical QC Guide

  2026-09-14

  The LDH Cytotoxicity Assay Kit provides a non-radioactive approach to cell cytotoxicity measurement by quantifying LDH released into culture medium after membrane damage. It is useful for comparative cell damage quantification and viability workflows, but it should not be used alone to identify a specific cell-death mechanism or to interpret samples with substantial background LDH or optical interference.

• L-Alanyl-L-Glutamine: GI Research Workflows

  2026-09-14

  Build reproducible gastrointestinal barrier experiments with a water-soluble L-Ala-L-Gln dipeptide designed for nutritional and stress-response studies. This guide connects practical dosing, barrier readouts, storage controls, and translational limitations without overstating evidence from unrelated disease models.

• Azathramycin A: Designing Better TB Assays

  2026-09-13

  Azathramycin A is a macrolide antibiotic for studying ribosome-directed protein synthesis inhibition in tuberculosis research. This article shows how to interpret its degradation-product chemistry, intracellular assay behavior, and related macrolide evidence without overstating what each experiment proves.

• EVMPs for Extrahepatic mRNA Delivery

  2026-09-12

  This ACS Nano study introduces a self-assembling enveloped virus-mimicking particle (EVMP) that combines a designed RNA-binding peptide with tunable phospholipid envelopes for extrahepatic mRNA delivery. The platform produced substantial lung-cell transfection and enabled IL-12 mRNA-mediated tumor suppression, while its simplified, nonviral architecture was designed to support repeat dosing and manufacturing flexibility.

• TH287: Timing the MTH1 Radiosensitization Window

  2026-09-12

  TH287 turns oxidized nucleotide stress into a testable cancer vulnerability. Recent CRPC data suggest that the timing of TH287 exposure before ionizing radiation may be as important as dose, creating a translational framework for studying MTH1 inhibition, DNA damage, and radiosensitization.

• ω-Agatoxin IVA and Excitotoxicity

  2026-09-11

  The 1996 study tested whether blocking P- and Q-type calcium channels with ω-agatoxin IVA could reduce excitotoxic injury in cortical neuron-enriched cultures. Its central finding was negative but important: inhibition of toxin-sensitive calcium channels did not protect cells from veratridine-, ouabain-, or NMDA-induced injury under the tested conditions, cautioning against equating reduced glutamate release with neuroprotection.

• Propidium Iodide Workflows for Cell Analysis

  2026-09-11

  Propidium iodide converts membrane damage and DNA content into measurable red fluorescence for cell viability assay, apoptosis detection, and cell cycle analysis workflows. This guide connects practical PI staining with the reference study on ATR inhibition and ALT-positive cancer cells, helping researchers separate genuine drug effects from cell-line and handling artifacts.

• EMD638683: SGK1 Inhibitor Research Workflows

  2026-09-10

  EMD638683 enables time-controlled SGK pathway interrogation across endothelial stiffness, sodium-channel signaling, NDRG1 phosphorylation, and tumor-cell stress models. This workflow-focused guide covers formulation, assay design, comparative controls, and troubleshooting for vascular, hypertension, and cancer research.

• IBDV VP3 Disrupts IRF7 Antiviral Signaling

  2026-09-10

  The reference study identifies IBDV VP3 as a viral factor that suppresses chicken IRF7-mediated type I interferon responses by promoting proteasome-associated IRF7 loss. Its combination of viral strain comparison, IRF7 perturbation, pathway inhibition, and VP3 interaction analysis provides a useful framework for studying immune evasion through host protein stability.

• Angiotensin (1-7): A Smarter Assay Strategy

  2026-09-09

  Angiotensin (1-7) research is moving beyond receptor pharmacology toward sequence-resolved binding and pathway assays. This guide connects Mas receptor biology, peptide handling, and the 2025 spike–receptor study to improve experimental design and interpretation.

• Filipin III for Reliable Membrane Cholesterol Imaging

  2026-09-09

  This scenario-driven guide explains how Filipin III, SKU B6034, supports cholesterol detection in membranes without being mistaken for a direct viability assay. It covers experimental design, handling at −20°C and 37°C, controls, interpretation, and practical vendor selection for biomedical laboratories.

8570 records 1/572 page Next 12345 下5页 Last page